News

Wall Street plunges as Trump tariffs trigger recession fears

(Reuters) -Heavyweight technology stocks led a broad selloff on Wall Street on Thursday after President Donald Trump's sweeping tariffs on major trade partners ignited fears of an all-out trade war and raised the risk of a global economic recession. Investors fled from risky assets, seeking the safety of government bonds after Trump slapped a 10% tariff on most goods imported into the United States and much higher levies on dozens of other countries. High-flying technology stocks, that have pushed Wall Street to record highs in recent years, suffered big declines on Thursday.

Traders seek refuge in Aussie consumer staples as US tariffs spark market fall

Shares of Australia's consumer staple companies rose on Thursday, driven by grocers Coles and Woolworths, as investors moved to safer bets after U.S. President Donald Trump's reciprocal tariffs sparked global market turmoil. Coles rose 2.1% to A$20.29 and Woolworths advanced 1.6% to A$30.02. President Trump's decision to impose a 10% tariff on most goods imported to the United States sent shockwaves globally, sparking fears of an escalating trade war and a hit to global economic growth.

UBS Wealth, Templeton See Chinese Stocks Braving Tariff Blow

(Bloomberg) -- Some of the world’s biggest money managers say Chinese stocks have the means to weather the tariff blitz unleashed by US President Donald Trump on the economy.Most Read from BloombergMetro-North Is Faster Than Acela on NYC-New Haven Route After Signal UpdatesLondon Clears Final Hurdle for More High-Speed Trains to EuropeLocal Governments Vie for Fired Federal WorkersWhat Frank Lloyd Wright Learned From the DesertChicago School District Agrees to Minimum 16% Teacher Pay RaiseFund m

US tech, retail stocks lead rout after Trump's tariff blow

(Reuters) -Megacap U.S. tech companies including Apple and retail giants Walmart and Nike led a global market meltdown as President Donald Trump's sweeping new tariffs heightened fears of a spike in costs across a wide range of industries. The tariffs, which threaten to destabilize the world trade order and unsettle businesses, mark a sharp reversal from just a few months ago when hopes of business-friendly policies under the Trump administration pushed U.S. stocks to record highs. Trump said he would impose a 10% baseline tariff on all imports to the United States and higher duties on dozens of other countries, pushing U.S. tariffs to the highest in more than a century, according to Fitch Ratings.

Pharma stocks survive market rout on tariff exemption, but uncertainty continues

Drugmaker stocks gained a temporary reprieve on Thursday as U.S. President Donald Trump spared pharmaceutical products from reciprocal tariffs, but executives and analysts warned it was premature to celebrate as tariffs were still likely to come. Trump imposed a 10% tariff on most U.S. imports, as well as much higher levies on dozens of rivals and allies alike, but temporarily exempted some goods, including pharmaceuticals, benefiting major exporters including India, Japan and Ireland. Shares of U.S. drugmakers AbbVie and Johnson & Johnson rose about 2%, defying the broader market drop.